nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Pseudoephedrine—IL2—ulcerative colitis	0.00676	0.248	CrCbGaD
Dextroamphetamine—Amphetamine—SLC22A5—ulcerative colitis	0.00283	0.104	CrCbGaD
Dextroamphetamine—Ephedrine—ADRB2—ulcerative colitis	0.00267	0.0981	CrCbGaD
Dextroamphetamine—Methamphetamine—SLC22A5—ulcerative colitis	0.00262	0.0962	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRB2—ulcerative colitis	0.00239	0.088	CrCbGaD
Dextroamphetamine—Pseudoephedrine—TNF—ulcerative colitis	0.00228	0.0839	CrCbGaD
Dextroamphetamine—Nateglinide—PPARG—ulcerative colitis	0.00224	0.0823	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRB2—ulcerative colitis	0.00202	0.0743	CrCbGaD
Dextroamphetamine—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.00187	0.00264	CcSEcCtD
Dextroamphetamine—Infection—Azathioprine—ulcerative colitis	0.00187	0.00264	CcSEcCtD
Dextroamphetamine—Palpitations—Mesalazine—ulcerative colitis	0.00185	0.00262	CcSEcCtD
Dextroamphetamine—Dyspepsia—Budesonide—ulcerative colitis	0.00185	0.00262	CcSEcCtD
Dextroamphetamine—Decreased appetite—Budesonide—ulcerative colitis	0.00183	0.00259	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00182	0.00257	CcSEcCtD
Dextroamphetamine—Nausea—Nicotine—ulcerative colitis	0.00181	0.00257	CcSEcCtD
Dextroamphetamine—Fatigue—Budesonide—ulcerative colitis	0.00181	0.00256	CcSEcCtD
Dextroamphetamine—Affect lability—Prednisone—ulcerative colitis	0.00181	0.00256	CcSEcCtD
Dextroamphetamine—Hypertension—Mesalazine—ulcerative colitis	0.00181	0.00256	CcSEcCtD
Dextroamphetamine—Constipation—Budesonide—ulcerative colitis	0.0018	0.00254	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Prednisone—ulcerative colitis	0.0018	0.00254	CcSEcCtD
Dextroamphetamine—Chest pain—Mesalazine—ulcerative colitis	0.00178	0.00252	CcSEcCtD
Dextroamphetamine—Anxiety—Mesalazine—ulcerative colitis	0.00178	0.00251	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.00177	0.0025	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.00177	0.0025	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Triamcinolone—ulcerative colitis	0.00176	0.00249	CcSEcCtD
Dextroamphetamine—Irritability—Prednisone—ulcerative colitis	0.00176	0.00249	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.00176	0.00248	CcSEcCtD
Dextroamphetamine—Dry mouth—Mesalazine—ulcerative colitis	0.00175	0.00247	CcSEcCtD
Dextroamphetamine—Mood swings—Prednisone—ulcerative colitis	0.00174	0.00247	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Budesonide—ulcerative colitis	0.00172	0.00243	CcSEcCtD
Dextroamphetamine—Sweating—Methylprednisolone—ulcerative colitis	0.00172	0.00243	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Mesalazine—ulcerative colitis	0.00171	0.00242	CcSEcCtD
Dextroamphetamine—Infection—Mesalazine—ulcerative colitis	0.0017	0.0024	CcSEcCtD
Dextroamphetamine—Urticaria—Budesonide—ulcerative colitis	0.00167	0.00236	CcSEcCtD
Dextroamphetamine—Tachycardia—Mesalazine—ulcerative colitis	0.00167	0.00236	CcSEcCtD
Dextroamphetamine—Abdominal pain—Budesonide—ulcerative colitis	0.00166	0.00235	CcSEcCtD
Dextroamphetamine—Body temperature increased—Budesonide—ulcerative colitis	0.00166	0.00235	CcSEcCtD
Dextroamphetamine—Nateglinide—PTGS1—ulcerative colitis	0.00165	0.0608	CrCbGaD
Dextroamphetamine—Hyperhidrosis—Mesalazine—ulcerative colitis	0.00165	0.00234	CcSEcCtD
Dextroamphetamine—Weight decreased—Dexamethasone—ulcerative colitis	0.00165	0.00234	CcSEcCtD
Dextroamphetamine—Weight decreased—Betamethasone—ulcerative colitis	0.00165	0.00234	CcSEcCtD
Dextroamphetamine—Anorexia—Mesalazine—ulcerative colitis	0.00163	0.00231	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00162	0.00229	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.00161	0.00227	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.00161	0.00227	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Betamethasone—ulcerative colitis	0.0016	0.00226	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Dexamethasone—ulcerative colitis	0.0016	0.00226	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Budesonide—ulcerative colitis	0.00155	0.00219	CcSEcCtD
Dextroamphetamine—Insomnia—Mesalazine—ulcerative colitis	0.00155	0.00219	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.00154	0.00217	CcSEcCtD
Dextroamphetamine—Dyspnoea—Mesalazine—ulcerative colitis	0.00152	0.00216	CcSEcCtD
Dextroamphetamine—Somnolence—Mesalazine—ulcerative colitis	0.00152	0.00215	CcSEcCtD
Dextroamphetamine—Asthenia—Budesonide—ulcerative colitis	0.00151	0.00213	CcSEcCtD
Dextroamphetamine—Dyspepsia—Mesalazine—ulcerative colitis	0.00151	0.00213	CcSEcCtD
Dextroamphetamine—Decreased appetite—Mesalazine—ulcerative colitis	0.00149	0.0021	CcSEcCtD
Dextroamphetamine—Abdominal pain—Azathioprine—ulcerative colitis	0.00148	0.0021	CcSEcCtD
Dextroamphetamine—Body temperature increased—Azathioprine—ulcerative colitis	0.00148	0.0021	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00148	0.00209	CcSEcCtD
Dextroamphetamine—Fatigue—Mesalazine—ulcerative colitis	0.00147	0.00209	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Prednisone—ulcerative colitis	0.00147	0.00207	CcSEcCtD
Dextroamphetamine—Constipation—Mesalazine—ulcerative colitis	0.00146	0.00207	CcSEcCtD
Dextroamphetamine—Weight decreased—Prednisone—ulcerative colitis	0.00144	0.00204	CcSEcCtD
Dextroamphetamine—Diarrhoea—Budesonide—ulcerative colitis	0.00144	0.00203	CcSEcCtD
Dextroamphetamine—Depression—Prednisone—ulcerative colitis	0.00141	0.002	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Prednisone—ulcerative colitis	0.0014	0.00198	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.0014	0.00198	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisolone—ulcerative colitis	0.00139	0.00197	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisone—ulcerative colitis	0.00139	0.00197	CcSEcCtD
Dextroamphetamine—Dizziness—Budesonide—ulcerative colitis	0.00139	0.00197	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Azathioprine—ulcerative colitis	0.00138	0.00196	CcSEcCtD
Dextroamphetamine—Angioedema—Hydrocortisone—ulcerative colitis	0.00136	0.00193	CcSEcCtD
Dextroamphetamine—Urticaria—Mesalazine—ulcerative colitis	0.00136	0.00192	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mesalazine—ulcerative colitis	0.00135	0.00191	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mesalazine—ulcerative colitis	0.00135	0.00191	CcSEcCtD
Dextroamphetamine—Vomiting—Budesonide—ulcerative colitis	0.00134	0.00189	CcSEcCtD
Dextroamphetamine—Rash—Budesonide—ulcerative colitis	0.00133	0.00188	CcSEcCtD
Dextroamphetamine—Dermatitis—Budesonide—ulcerative colitis	0.00132	0.00187	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisolone—ulcerative colitis	0.00132	0.00187	CcSEcCtD
Dextroamphetamine—Headache—Budesonide—ulcerative colitis	0.00132	0.00186	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisolone—ulcerative colitis	0.00132	0.00186	CcSEcCtD
Dextroamphetamine—Convulsion—Hydrocortisone—ulcerative colitis	0.00129	0.00183	CcSEcCtD
Dextroamphetamine—Hypertension—Hydrocortisone—ulcerative colitis	0.00129	0.00182	CcSEcCtD
Dextroamphetamine—Diarrhoea—Azathioprine—ulcerative colitis	0.00128	0.00182	CcSEcCtD
Dextroamphetamine—Angioedema—Triamcinolone—ulcerative colitis	0.00128	0.00181	CcSEcCtD
Dextroamphetamine—Angioedema—Methylprednisolone—ulcerative colitis	0.00128	0.00181	CcSEcCtD
Dextroamphetamine—Anxiety—Hydrocortisone—ulcerative colitis	0.00126	0.00179	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Mesalazine—ulcerative colitis	0.00126	0.00178	CcSEcCtD
Dextroamphetamine—Nausea—Budesonide—ulcerative colitis	0.00125	0.00177	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisolone—ulcerative colitis	0.00125	0.00176	CcSEcCtD
Dextroamphetamine—Dizziness—Azathioprine—ulcerative colitis	0.00124	0.00176	CcSEcCtD
Dextroamphetamine—Asthenia—Mesalazine—ulcerative colitis	0.00123	0.00174	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.00122	0.00172	CcSEcCtD
Dextroamphetamine—Convulsion—Triamcinolone—ulcerative colitis	0.00122	0.00172	CcSEcCtD
Dextroamphetamine—Tachycardia—Prednisolone—ulcerative colitis	0.00122	0.00172	CcSEcCtD
Dextroamphetamine—Convulsion—Methylprednisolone—ulcerative colitis	0.00121	0.00172	CcSEcCtD
Dextroamphetamine—Hypertension—Triamcinolone—ulcerative colitis	0.00121	0.00171	CcSEcCtD
Dextroamphetamine—Hypertension—Methylprednisolone—ulcerative colitis	0.00121	0.00171	CcSEcCtD
Dextroamphetamine—Infection—Hydrocortisone—ulcerative colitis	0.00121	0.00171	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisolone—ulcerative colitis	0.0012	0.0017	CcSEcCtD
Dextroamphetamine—Vomiting—Azathioprine—ulcerative colitis	0.00119	0.00169	CcSEcCtD
Dextroamphetamine—Anxiety—Methylprednisolone—ulcerative colitis	0.00119	0.00168	CcSEcCtD
Dextroamphetamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.00119	0.00168	CcSEcCtD
Dextroamphetamine—Rash—Azathioprine—ulcerative colitis	0.00118	0.00167	CcSEcCtD
Dextroamphetamine—Dermatitis—Azathioprine—ulcerative colitis	0.00118	0.00167	CcSEcCtD
Dextroamphetamine—Headache—Azathioprine—ulcerative colitis	0.00118	0.00166	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00118	0.00166	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mesalazine—ulcerative colitis	0.00117	0.00165	CcSEcCtD
Dextroamphetamine—Dry mouth—Triamcinolone—ulcerative colitis	0.00117	0.00165	CcSEcCtD
Dextroamphetamine—Angioedema—Betamethasone—ulcerative colitis	0.00116	0.00165	CcSEcCtD
Dextroamphetamine—Angioedema—Dexamethasone—ulcerative colitis	0.00116	0.00165	CcSEcCtD
Dextroamphetamine—Anorexia—Hydrocortisone—ulcerative colitis	0.00116	0.00164	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.00115	0.00162	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.00114	0.00162	CcSEcCtD
Dextroamphetamine—Infection—Triamcinolone—ulcerative colitis	0.00114	0.00161	CcSEcCtD
Dextroamphetamine—Infection—Methylprednisolone—ulcerative colitis	0.00114	0.00161	CcSEcCtD
Dextroamphetamine—Dizziness—Mesalazine—ulcerative colitis	0.00113	0.0016	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisolone—ulcerative colitis	0.00113	0.00159	CcSEcCtD
Dextroamphetamine—Tachycardia—Triamcinolone—ulcerative colitis	0.00112	0.00158	CcSEcCtD
Dextroamphetamine—Nausea—Azathioprine—ulcerative colitis	0.00112	0.00158	CcSEcCtD
Dextroamphetamine—Tachycardia—Methylprednisolone—ulcerative colitis	0.00112	0.00158	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.00111	0.00157	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.0011	0.00156	CcSEcCtD
Dextroamphetamine—Convulsion—Betamethasone—ulcerative colitis	0.0011	0.00156	CcSEcCtD
Dextroamphetamine—Convulsion—Dexamethasone—ulcerative colitis	0.0011	0.00156	CcSEcCtD
Dextroamphetamine—Insomnia—Hydrocortisone—ulcerative colitis	0.0011	0.00156	CcSEcCtD
Dextroamphetamine—Hypertension—Dexamethasone—ulcerative colitis	0.0011	0.00155	CcSEcCtD
Dextroamphetamine—Hypertension—Betamethasone—ulcerative colitis	0.0011	0.00155	CcSEcCtD
Dextroamphetamine—Vomiting—Mesalazine—ulcerative colitis	0.00109	0.00154	CcSEcCtD
Dextroamphetamine—Anxiety—Betamethasone—ulcerative colitis	0.00108	0.00153	CcSEcCtD
Dextroamphetamine—Anxiety—Dexamethasone—ulcerative colitis	0.00108	0.00153	CcSEcCtD
Dextroamphetamine—Rash—Mesalazine—ulcerative colitis	0.00108	0.00153	CcSEcCtD
Dextroamphetamine—Dermatitis—Mesalazine—ulcerative colitis	0.00108	0.00152	CcSEcCtD
Dextroamphetamine—Headache—Mesalazine—ulcerative colitis	0.00107	0.00152	CcSEcCtD
Dextroamphetamine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00107	0.00151	CcSEcCtD
Dextroamphetamine—Decreased appetite—Hydrocortisone—ulcerative colitis	0.00106	0.0015	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00105	0.00148	CcSEcCtD
Dextroamphetamine—Fatigue—Hydrocortisone—ulcerative colitis	0.00105	0.00148	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Betamethasone—ulcerative colitis	0.00104	0.00147	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.00104	0.00147	CcSEcCtD
Dextroamphetamine—Insomnia—Triamcinolone—ulcerative colitis	0.00104	0.00146	CcSEcCtD
Dextroamphetamine—Insomnia—Methylprednisolone—ulcerative colitis	0.00103	0.00146	CcSEcCtD
Dextroamphetamine—Infection—Dexamethasone—ulcerative colitis	0.00103	0.00146	CcSEcCtD
Dextroamphetamine—Infection—Betamethasone—ulcerative colitis	0.00103	0.00146	CcSEcCtD
Dextroamphetamine—Dyspnoea—Triamcinolone—ulcerative colitis	0.00102	0.00144	CcSEcCtD
Dextroamphetamine—Agitation—Prednisone—ulcerative colitis	0.00102	0.00144	CcSEcCtD
Dextroamphetamine—Nausea—Mesalazine—ulcerative colitis	0.00102	0.00144	CcSEcCtD
Dextroamphetamine—Tachycardia—Betamethasone—ulcerative colitis	0.00101	0.00143	CcSEcCtD
Dextroamphetamine—Tachycardia—Dexamethasone—ulcerative colitis	0.00101	0.00143	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisone—ulcerative colitis	0.00101	0.00143	CcSEcCtD
Dextroamphetamine—Dyspepsia—Triamcinolone—ulcerative colitis	0.00101	0.00143	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00101	0.00142	CcSEcCtD
Dextroamphetamine—SLC6A2—Monoamine Transport—TNF—ulcerative colitis	0.001	0.00378	CbGpPWpGaD
Dextroamphetamine—Hyperhidrosis—Betamethasone—ulcerative colitis	0.001	0.00142	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.001	0.00142	CcSEcCtD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—ulcerative colitis	0.001	0.00378	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000995	0.00141	CcSEcCtD
Dextroamphetamine—Anorexia—Betamethasone—ulcerative colitis	0.000991	0.0014	CcSEcCtD
Dextroamphetamine—Anorexia—Dexamethasone—ulcerative colitis	0.000991	0.0014	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisolone—ulcerative colitis	0.000989	0.0014	CcSEcCtD
Dextroamphetamine—Fatigue—Triamcinolone—ulcerative colitis	0.000987	0.0014	CcSEcCtD
Dextroamphetamine—Fatigue—Methylprednisolone—ulcerative colitis	0.000985	0.00139	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—GNA12—ulcerative colitis	0.000967	0.00364	CbGpPWpGaD
Dextroamphetamine—Urticaria—Hydrocortisone—ulcerative colitis	0.000966	0.00137	CcSEcCtD
Dextroamphetamine—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000962	0.00136	CcSEcCtD
Dextroamphetamine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000962	0.00136	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisone—ulcerative colitis	0.000961	0.00136	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisone—ulcerative colitis	0.000957	0.00135	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000949	0.00357	CbGpPWpGaD
Dextroamphetamine—Anxiety—Prednisone—ulcerative colitis	0.000941	0.00133	CcSEcCtD
Dextroamphetamine—Insomnia—Dexamethasone—ulcerative colitis	0.00094	0.00133	CcSEcCtD
Dextroamphetamine—Insomnia—Betamethasone—ulcerative colitis	0.00094	0.00133	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000934	0.00132	CcSEcCtD
Dextroamphetamine—SLC18A2—Neuronal System—CALM3—ulcerative colitis	0.000919	0.00346	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000918	0.0013	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000916	0.00345	CbGpPWpGaD
Dextroamphetamine—Dyspepsia—Dexamethasone—ulcerative colitis	0.000915	0.00129	CcSEcCtD
Dextroamphetamine—Dyspepsia—Betamethasone—ulcerative colitis	0.000915	0.00129	CcSEcCtD
Dextroamphetamine—Urticaria—Triamcinolone—ulcerative colitis	0.00091	0.00129	CcSEcCtD
Dextroamphetamine—Urticaria—Methylprednisolone—ulcerative colitis	0.000908	0.00128	CcSEcCtD
Dextroamphetamine—Body temperature increased—Triamcinolone—ulcerative colitis	0.000905	0.00128	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisone—ulcerative colitis	0.000905	0.00128	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000903	0.00128	CcSEcCtD
Dextroamphetamine—Decreased appetite—Dexamethasone—ulcerative colitis	0.000903	0.00128	CcSEcCtD
Dextroamphetamine—Decreased appetite—Betamethasone—ulcerative colitis	0.000903	0.00128	CcSEcCtD
Dextroamphetamine—Selegiline—ABCB1—ulcerative colitis	0.0009	0.0331	CrCbGaD
Dextroamphetamine—Infection—Prednisone—ulcerative colitis	0.000899	0.00127	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000897	0.00127	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000897	0.00127	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000896	0.00127	CcSEcCtD
Dextroamphetamine—Fatigue—Dexamethasone—ulcerative colitis	0.000896	0.00127	CcSEcCtD
Dextroamphetamine—Fatigue—Betamethasone—ulcerative colitis	0.000896	0.00127	CcSEcCtD
Dextroamphetamine—SLC6A3—Monoamine Transport—TNF—ulcerative colitis	0.00089	0.00335	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000885	0.00333	CbGpPWpGaD
Dextroamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000884	0.00333	CbGpPWpGaD
Dextroamphetamine—Tachycardia—Prednisone—ulcerative colitis	0.000883	0.00125	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisone—ulcerative colitis	0.000875	0.00124	CcSEcCtD
Dextroamphetamine—Asthenia—Hydrocortisone—ulcerative colitis	0.000873	0.00123	CcSEcCtD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.00087	0.00328	CbGpPWpGaD
Dextroamphetamine—Anorexia—Prednisone—ulcerative colitis	0.000863	0.00122	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCR6—ulcerative colitis	0.000861	0.00324	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.00085	0.0012	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.00085	0.0012	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000844	0.00119	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—ulcerative colitis	0.000843	0.031	CrCbGaD
Dextroamphetamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000842	0.00119	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—SEL1L—ulcerative colitis	0.00084	0.00316	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000835	0.00314	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000832	0.00118	CcSEcCtD
Dextroamphetamine—Urticaria—Dexamethasone—ulcerative colitis	0.000826	0.00117	CcSEcCtD
Dextroamphetamine—Urticaria—Betamethasone—ulcerative colitis	0.000826	0.00117	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisolone—ulcerative colitis	0.000824	0.00116	CcSEcCtD
Dextroamphetamine—Asthenia—Triamcinolone—ulcerative colitis	0.000822	0.00116	CcSEcCtD
Dextroamphetamine—Abdominal pain—Betamethasone—ulcerative colitis	0.000822	0.00116	CcSEcCtD
Dextroamphetamine—Abdominal pain—Dexamethasone—ulcerative colitis	0.000822	0.00116	CcSEcCtD
Dextroamphetamine—Body temperature increased—Betamethasone—ulcerative colitis	0.000822	0.00116	CcSEcCtD
Dextroamphetamine—Body temperature increased—Dexamethasone—ulcerative colitis	0.000822	0.00116	CcSEcCtD
Dextroamphetamine—Asthenia—Methylprednisolone—ulcerative colitis	0.00082	0.00116	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisone—ulcerative colitis	0.000819	0.00116	CcSEcCtD
Dextroamphetamine—Dizziness—Hydrocortisone—ulcerative colitis	0.000804	0.00114	CcSEcCtD
Dextroamphetamine—Dyspepsia—Prednisone—ulcerative colitis	0.000797	0.00113	CcSEcCtD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.00079	0.00298	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000788	0.00297	CbGpPWpGaD
Dextroamphetamine—Decreased appetite—Prednisone—ulcerative colitis	0.000787	0.00111	CcSEcCtD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000786	0.00296	CbGpPWpGaD
Dextroamphetamine—Rash—Prednisolone—ulcerative colitis	0.000785	0.00111	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisolone—ulcerative colitis	0.000785	0.00111	CcSEcCtD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000783	0.00295	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000782	0.00111	CcSEcCtD
Dextroamphetamine—Fatigue—Prednisone—ulcerative colitis	0.00078	0.0011	CcSEcCtD
Dextroamphetamine—Headache—Prednisolone—ulcerative colitis	0.00078	0.0011	CcSEcCtD
Dextroamphetamine—Constipation—Prednisone—ulcerative colitis	0.000774	0.00109	CcSEcCtD
Dextroamphetamine—Vomiting—Hydrocortisone—ulcerative colitis	0.000773	0.00109	CcSEcCtD
Dextroamphetamine—Rash—Hydrocortisone—ulcerative colitis	0.000767	0.00108	CcSEcCtD
Dextroamphetamine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000766	0.00108	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000765	0.00288	CbGpPWpGaD
Dextroamphetamine—Headache—Hydrocortisone—ulcerative colitis	0.000762	0.00108	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000758	0.00286	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000758	0.00285	CbGpPWpGaD
Dextroamphetamine—Dizziness—Triamcinolone—ulcerative colitis	0.000757	0.00107	CcSEcCtD
Dextroamphetamine—Dizziness—Methylprednisolone—ulcerative colitis	0.000756	0.00107	CcSEcCtD
Dextroamphetamine—Asthenia—Dexamethasone—ulcerative colitis	0.000746	0.00105	CcSEcCtD
Dextroamphetamine—Asthenia—Betamethasone—ulcerative colitis	0.000746	0.00105	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.00074	0.00105	CcSEcCtD
Dextroamphetamine—Nausea—Prednisolone—ulcerative colitis	0.00074	0.00105	CcSEcCtD
Dextroamphetamine—Vomiting—Triamcinolone—ulcerative colitis	0.000728	0.00103	CcSEcCtD
Dextroamphetamine—Vomiting—Methylprednisolone—ulcerative colitis	0.000727	0.00103	CcSEcCtD
Dextroamphetamine—Nausea—Hydrocortisone—ulcerative colitis	0.000722	0.00102	CcSEcCtD
Dextroamphetamine—Rash—Triamcinolone—ulcerative colitis	0.000722	0.00102	CcSEcCtD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000722	0.00272	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000722	0.00272	CbGpPWpGaD
Dextroamphetamine—Dermatitis—Triamcinolone—ulcerative colitis	0.000721	0.00102	CcSEcCtD
Dextroamphetamine—Rash—Methylprednisolone—ulcerative colitis	0.000721	0.00102	CcSEcCtD
Dextroamphetamine—Dermatitis—Methylprednisolone—ulcerative colitis	0.00072	0.00102	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisone—ulcerative colitis	0.000719	0.00102	CcSEcCtD
Dextroamphetamine—Headache—Triamcinolone—ulcerative colitis	0.000717	0.00101	CcSEcCtD
Dextroamphetamine—Headache—Methylprednisolone—ulcerative colitis	0.000716	0.00101	CcSEcCtD
Dextroamphetamine—Body temperature increased—Prednisone—ulcerative colitis	0.000715	0.00101	CcSEcCtD
Dextroamphetamine—Abdominal pain—Prednisone—ulcerative colitis	0.000715	0.00101	CcSEcCtD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000715	0.00269	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Dexamethasone—ulcerative colitis	0.000711	0.00101	CcSEcCtD
Dextroamphetamine—Diarrhoea—Betamethasone—ulcerative colitis	0.000711	0.00101	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00071	0.00267	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.0007	0.00264	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—GHRL—ulcerative colitis	0.000694	0.00261	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000692	0.00261	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCR1—ulcerative colitis	0.000692	0.0026	CbGpPWpGaD
Dextroamphetamine—Dizziness—Betamethasone—ulcerative colitis	0.000687	0.000972	CcSEcCtD
Dextroamphetamine—Dizziness—Dexamethasone—ulcerative colitis	0.000687	0.000972	CcSEcCtD
Dextroamphetamine—Nausea—Triamcinolone—ulcerative colitis	0.00068	0.000962	CcSEcCtD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—RELA—ulcerative colitis	0.000679	0.00256	CbGpPWpGaD
Dextroamphetamine—Nausea—Methylprednisolone—ulcerative colitis	0.000679	0.00096	CcSEcCtD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000679	0.00256	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.000674	0.00254	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000673	0.00253	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CALM3—ulcerative colitis	0.000673	0.00253	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000668	0.00251	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—ADCY5—ulcerative colitis	0.000667	0.00251	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Prednisone—ulcerative colitis	0.000667	0.000943	CcSEcCtD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000665	0.00251	CbGpPWpGaD
Dextroamphetamine—Vomiting—Dexamethasone—ulcerative colitis	0.000661	0.000934	CcSEcCtD
Dextroamphetamine—Vomiting—Betamethasone—ulcerative colitis	0.000661	0.000934	CcSEcCtD
Dextroamphetamine—Rash—Betamethasone—ulcerative colitis	0.000655	0.000927	CcSEcCtD
Dextroamphetamine—Rash—Dexamethasone—ulcerative colitis	0.000655	0.000927	CcSEcCtD
Dextroamphetamine—Dermatitis—Dexamethasone—ulcerative colitis	0.000655	0.000926	CcSEcCtD
Dextroamphetamine—Dermatitis—Betamethasone—ulcerative colitis	0.000655	0.000926	CcSEcCtD
Dextroamphetamine—Headache—Dexamethasone—ulcerative colitis	0.000651	0.000921	CcSEcCtD
Dextroamphetamine—Headache—Betamethasone—ulcerative colitis	0.000651	0.000921	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000651	0.00245	CbGpPWpGaD
Dextroamphetamine—Asthenia—Prednisone—ulcerative colitis	0.000649	0.000918	CcSEcCtD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—CXCL8—ulcerative colitis	0.00064	0.00241	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000639	0.00241	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000639	0.00241	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000633	0.00238	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Prednisone—ulcerative colitis	0.000619	0.000876	CcSEcCtD
Dextroamphetamine—Nausea—Dexamethasone—ulcerative colitis	0.000617	0.000873	CcSEcCtD
Dextroamphetamine—Nausea—Betamethasone—ulcerative colitis	0.000617	0.000873	CcSEcCtD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000615	0.00232	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL20—ulcerative colitis	0.000607	0.00229	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000607	0.00229	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000603	0.00227	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.000598	0.00225	CbGpPWpGaD
Dextroamphetamine—Dizziness—Prednisone—ulcerative colitis	0.000598	0.000846	CcSEcCtD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000593	0.00223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000591	0.00223	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.00058	0.00218	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—MMP9—ulcerative colitis	0.000579	0.00218	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000578	0.00218	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCR1—ulcerative colitis	0.000577	0.00217	CbGpPWpGaD
Dextroamphetamine—Vomiting—Prednisone—ulcerative colitis	0.000575	0.000814	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000575	0.00216	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000573	0.00216	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—NFKB1—ulcerative colitis	0.000573	0.00216	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000572	0.00215	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GNA12—ulcerative colitis	0.000571	0.00215	CbGpPWpGaD
Dextroamphetamine—Rash—Prednisone—ulcerative colitis	0.000571	0.000807	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisone—ulcerative colitis	0.00057	0.000806	CcSEcCtD
Dextroamphetamine—Headache—Prednisone—ulcerative colitis	0.000567	0.000802	CcSEcCtD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000558	0.0021	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—CALM3—ulcerative colitis	0.000548	0.00206	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCR2—ulcerative colitis	0.000541	0.00204	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000541	0.00204	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000539	0.00203	CbGpPWpGaD
Dextroamphetamine—Nausea—Prednisone—ulcerative colitis	0.000538	0.00076	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000537	0.00202	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000527	0.00198	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000519	0.00195	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCR1—ulcerative colitis	0.000513	0.00193	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000509	0.00192	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCR6—ulcerative colitis	0.000509	0.00192	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000508	0.00191	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL20—ulcerative colitis	0.000507	0.00191	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000495	0.00187	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000491	0.00185	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000488	0.00184	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MAML2—ulcerative colitis	0.000482	0.00182	CbGpPWpGaD
Dextroamphetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000473	0.00178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCR2—ulcerative colitis	0.000452	0.0017	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL20—ulcerative colitis	0.00045	0.00169	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000449	0.00169	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000449	0.00169	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PTGER4—ulcerative colitis	0.000448	0.00169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000436	0.00164	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000434	0.00164	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCR6—ulcerative colitis	0.000425	0.0016	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	0.00042	0.00158	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GHRL—ulcerative colitis	0.00041	0.00154	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCR2—ulcerative colitis	0.000401	0.00151	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000399	0.0015	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000398	0.0015	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—ADCY5—ulcerative colitis	0.000398	0.0015	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CALM3—ulcerative colitis	0.000397	0.0015	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—RIPK2—ulcerative colitis	0.000391	0.00147	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000386	0.00145	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000384	0.00145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCR6—ulcerative colitis	0.000377	0.00142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—PTGER4—ulcerative colitis	0.000374	0.00141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000372	0.0014	CbGpPWpGaD
Dextroamphetamine—ADRA1B—AMPK Signaling—TP53—ulcerative colitis	0.00037	0.00139	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000359	0.00135	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—GHRL—ulcerative colitis	0.000342	0.00129	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ADRB2—ulcerative colitis	0.00034	0.00128	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000335	0.00126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—PTGER4—ulcerative colitis	0.000332	0.00125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00033	0.00124	CbGpPWpGaD
Dextroamphetamine—ADRA1A—AMPK Signaling—TP53—ulcerative colitis	0.000328	0.00124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000326	0.00123	CbGpPWpGaD
Dextroamphetamine—SLC6A2—NRF2 pathway—TGFB1—ulcerative colitis	0.00032	0.0012	CbGpPWpGaD
Dextroamphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000318	0.0012	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000306	0.00115	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—JAK2—ulcerative colitis	0.000304	0.00115	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—GHRL—ulcerative colitis	0.000304	0.00114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCR1—ulcerative colitis	0.000296	0.00112	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—IL2—ulcerative colitis	0.000292	0.0011	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00029	0.00109	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ADCY5—ulcerative colitis	0.000288	0.00109	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCL20—ulcerative colitis	0.000286	0.00108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—ADRB2—ulcerative colitis	0.000283	0.00107	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—TGFB1—ulcerative colitis	0.000283	0.00107	CbGpPWpGaD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000282	0.00106	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000278	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GNA12—ulcerative colitis	0.000269	0.00101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000266	0.001	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL2—ulcerative colitis	0.000265	0.000999	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000263	0.000991	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL20—ulcerative colitis	0.00026	0.000979	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000259	0.000974	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000255	0.000961	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000254	0.000958	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—ADRB2—ulcerative colitis	0.000252	0.000948	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GNA12—ulcerative colitis	0.000245	0.000921	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000241	0.000908	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.00024	0.000905	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR6—ulcerative colitis	0.00024	0.000904	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GNA12—ulcerative colitis	0.000239	0.0009	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000236	0.000889	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCR2—ulcerative colitis	0.000232	0.000873	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL20—ulcerative colitis	0.000231	0.00087	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000229	0.000863	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000227	0.000854	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR6—ulcerative colitis	0.000218	0.000821	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GNA12—ulcerative colitis	0.000217	0.000818	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000214	0.000805	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR6—ulcerative colitis	0.000213	0.000803	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SEL1L—ulcerative colitis	0.000212	0.0008	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000211	0.000795	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCR2—ulcerative colitis	0.000206	0.000775	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR6—ulcerative colitis	0.000194	0.000729	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GHRL—ulcerative colitis	0.000193	0.000728	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTGER4—ulcerative colitis	0.000192	0.000722	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SEL1L—ulcerative colitis	0.000189	0.000711	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000188	0.000707	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00018	0.000677	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—JAK2—ulcerative colitis	0.00018	0.000677	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GHRL—ulcerative colitis	0.000176	0.000661	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCR1—ulcerative colitis	0.000175	0.000659	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—RELA—ulcerative colitis	0.000174	0.000655	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CHP1—ulcerative colitis	0.000172	0.000648	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000172	0.000647	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	0.00017	0.000642	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CALM3—ulcerative colitis	0.00017	0.000641	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL8—ulcerative colitis	0.000164	0.000617	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000162	0.000609	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00016	0.000603	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00016	0.000601	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2—ulcerative colitis	0.000157	0.00059	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	0.000156	0.000587	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL6—ulcerative colitis	0.000156	0.000587	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	0.000155	0.000585	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL20—ulcerative colitis	0.000154	0.000578	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	0.000151	0.000569	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DLD—ulcerative colitis	0.000148	0.000559	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP9—ulcerative colitis	0.000148	0.000558	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NFKB1—ulcerative colitis	0.000147	0.000553	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	0.000145	0.000547	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	0.000144	0.000544	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000143	0.00054	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000142	0.000536	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	0.000137	0.000516	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	0.000137	0.000515	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	0.000136	0.000514	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000136	0.000513	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000136	0.000512	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT3—ulcerative colitis	0.000132	0.000497	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	0.000129	0.000486	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	0.000129	0.000485	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	0.000128	0.000483	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	0.000123	0.000465	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TGFB1—ulcerative colitis	0.000122	0.00046	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	0.000122	0.00046	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	0.000122	0.000458	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	0.000122	0.000458	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000121	0.000456	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000121	0.000455	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	0.000114	0.000431	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	0.000113	0.000427	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	0.00011	0.000413	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	0.000108	0.000408	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	0.000104	0.000391	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	0.000101	0.000379	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—ulcerative colitis	0.000101	0.000379	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	0.0001	0.000378	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	9.9e-05	0.000373	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	9.22e-05	0.000347	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—ulcerative colitis	9.21e-05	0.000347	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	8.93e-05	0.000336	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	8.79e-05	0.000331	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	8.59e-05	0.000323	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	8.47e-05	0.000319	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	7.73e-05	0.000291	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	7.69e-05	0.00029	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	7.63e-05	0.000287	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	7.53e-05	0.000283	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	7.39e-05	0.000278	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	7.29e-05	0.000275	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	7.18e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	7.02e-05	0.000264	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	6.87e-05	0.000259	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	6.83e-05	0.000257	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	6.71e-05	0.000253	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	6.56e-05	0.000247	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	6.48e-05	0.000244	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CALM3—ulcerative colitis	6.46e-05	0.000243	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	6.24e-05	0.000235	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	5.96e-05	0.000224	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	5.03e-05	0.000189	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	4.69e-05	0.000177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	4.55e-05	0.000171	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	4.4e-05	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	4.15e-05	0.000156	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	4.04e-05	0.000152	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	3.96e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	3.94e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	3.91e-05	0.000147	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	3.75e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	3.71e-05	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	3.68e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	3.52e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	3.5e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—ulcerative colitis	3.5e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	3.34e-05	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	3.33e-05	0.000125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	3.3e-05	0.000124	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—ulcerative colitis	3.14e-05	0.000118	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	3.09e-05	0.000116	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	2.96e-05	0.000112	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.75e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	2.75e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	2.55e-05	9.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	2.33e-05	8.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	2.26e-05	8.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	2.07e-05	7.79e-05	CbGpPWpGaD
